Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Oramed Pharma reports data from exploratory study of oral insulin capsule

Sep. 20, 2010

BioCryst Pharmaceuticals' BCX-4208 shows efficacy in gout

Sep. 20, 2010

Genfit advances GFT-505 to phase II in type 2 diabetes

Sep. 20, 2010

Merck & Co. identifies new glucagon receptor antagonists

Sep. 20, 2010

FDA advisory committee does not recommend approval of lorcaserin for obesity

Sep. 20, 2010

Wintherix elects WX-04554 as lead drug for bone healing

Sep. 20, 2010

TransPharma completes phase Ia ViaDerm-GLP1 agonist trial

Sep. 17, 2010

Abbott responds to FDA advisory committee vote regarding sibutramine

Sep. 17, 2010

Lundbeck and Argenta disclose promising preclinical data on MCH1 receptor antagonists

Sep. 17, 2010

FDA approves Savient Pharmaceuticals' pegloticase for gout

Sep. 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...